爱泼斯坦-巴尔病毒
医学
内科学
共感染
肿瘤科
单变量分析
人乳头瘤病毒
入射(几何)
病毒
癌症
免疫学
多元分析
光学
物理
作者
Shannon S. Wu,Bonnie Chen,Christopher W. Fleming,Akeesha A. Shah,Christopher C. Griffith,Chaim Domb,Chandana A. Reddy,Shauna R. Campbell,N.M. Woody,Eric Lamarre,Robert R. Lorenz,B. Prendes,Joseph Scharpf,Larissa Schwartzman,J.L. Geiger,Shlomo A. Koyfman,Jamie A. Ku
出处
期刊:Head & neck
[Wiley]
日期:2022-01-18
卷期号:44 (4): 851-861
被引量:15
摘要
Abstract Background The prognostication of Epstein–Barr virus (EBV) and human papillomavirus (HPV) status in nasopharyngeal cancer (NPC) is unclear. Methods This retrospective study analyzed NPC from 2000 to 2019. Results Seventy‐eight patients were included: 43 EBV + , 12 HPV + , 23 EBV − /HPV − , and 0 EBV + /HPV + . All p16 + tumors were also positive for HPV‐CISH. Baseline characteristics were not different between groups except age, N‐classification, and Karnofsky Performance Scale (KPS) ( p < 0.05). For EBV + , HPV + , and EBV − /HPV − respectively, 3‐year overall survival (OS) was 89.9%, 69.8%, and 52.5% ( p = 0.006). EBV − /HPV − status was significantly associated with worse OS but not freedom from progression (FFP) on univariate analysis, and did not remain a significant predictor of OS after adjusting for KPS, age, and group stage. Conclusions EBV + NPC tumors were seen in younger, healthier patients than HPV + and EBV − tumors, and there were no cases of coinfection. The association of viral status with OS was insignificant after adjusting for KPS and age.
科研通智能强力驱动
Strongly Powered by AbleSci AI